•
Sep 30, 2024

Humana Q3 2024 Earnings Report

Humana's financial performance in Q3 2024 reflected solid earnings and updated financial guidance.

Key Takeaways

Humana reported a GAAP EPS of $3.98 and an adjusted EPS of $4.16 for Q3 2024. The company updated its full-year 2024 EPS guidance to at least $12.89 on a GAAP basis and at least $16.00 on an adjusted basis. Humana also raised its 2024 individual Medicare Advantage annual membership growth expectation.

Reported Q3 2024 GAAP EPS of $3.98 and adjusted EPS of $4.16.

Updated FY 2024 EPS guidance to at least $12.89 on a GAAP basis and at least $16.00 on an adjusted basis.

Affirmed FY 2024 Insurance segment benefit ratio of approximately 90 percent.

Raised 2024 individual Medicare Advantage annual membership growth by 40,000, anticipating approximately 265,000 new members, or about 5 percent growth.

Total Revenue
$29.4B
Previous year: $25.5B
+15.2%
EPS
$4.16
Previous year: $7.78
-46.5%
Gross Profit
$26.1B
Previous year: $23.2B
+12.6%
Cash and Equivalents
$5.12B
Previous year: $15.1B
-66.2%
Free Cash Flow
$1.73B
Previous year: $1.02B
+69.7%
Total Assets
$50B
Previous year: $55.9B
-10.6%

Humana

Humana

Humana Revenue by Segment

Forward Guidance

Humana updates its GAAP EPS guidance for the year ending December 31, 2024 (FY 2024) to 'at least $12.89', or 'at least $16.00' on an Adjusted basis.